%0 Journal Article %A Stephan Walrand %T The autumn COVID-19 boost dates in Europe are linked to latitudes and not to temperatures pointing vitamin D as a contributing factor %D 2020 %R 10.1101/2020.10.28.20221176 %J medRxiv %P 2020.10.28.20221176 %X Purpose Determining the triggering factor of the sudden boost of the daily new COVID-19 cases arising in most European countries during 2020 Autumn.Methods The dates of the boost were determined using a fitting of the two last months reported daily new cases in 18 European countries of latitude ranging from 39° to 62°.Results The study proves no correlation between the country boost date and its 2 weeks preceding temperature, but shows an impressive linear correlation with its latitude. The country boost date corresponds to the time when its sun UV daily dose drops below ≈30% of that of 0° latitude.Conclusions The previous studies, reporting a vitamin D blood level impact, compared COVID-19 severity between different patients populations and so can hardly discriminate whether the vitamin D blood level is a real factor of covid-19 severity or only a marker of another weakness being the primary severity factor. In contrary, the date of the boost is an intrapopulation observation and can thus only be triggered by a parameter globally affecting the population, i.e. the sun UV daily dose decreases. This result evidences that low vitamin blood D level is a contributing factor of COVID-19 severity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementnoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A all data used come from open databaseAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data referred in the paper come from open database %U https://www.medrxiv.org/content/medrxiv/early/2020/11/17/2020.10.28.20221176.full.pdf